Speakers

  • Nader G. ABRAHAM, Ph.D., Dr. H.C., New York Medical College, New York, NY, USA – “Use of Peripheral blood CD34 expansion for treatment of the infarcted heart, improving left function and survival”
  • Deepa BHARTIYA, M. Sc, Ph. D., National Institute for Research in Reproductive Health (NIRRH), Mumbai, India –  “Endogenous, Pluripotent VSELs Survive and Can Regenerate Non-functional Gonads: Paradigm Shift for Oncofertility”
  • Curt CIVIN, M.D., University of Maryland School of Medicine, Baltimore, MD, USA – “CD34 Wars”
  • Luc DOUAY, M.D., Ph.D., Université Pierre et Marie Curie-Paris, Centre de Recherches Saint Antoine (UMR_S938), Paris, France – “Large-scale production of red blood cells from stem cells: where are we?”
  • Michaela FONTENAY, M.D., Ph.D., Inserm U1016 – CNRS UMR8104 – Université Paris Descartes Groupe Hospitalier Cochin, Paris, France –  “Myelodysplastic syndromes shake up the hematopoietic cells hierarchy’s”
  • Robert P. GALE, M.D., Ph. D., Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK –  “Are CD34 cells the cells which engraft and why do we care about dose per Kg?”
  • Douglas LOSORDO, M.D., Clinical Professor of Medicine, New York University, New York, NY, USA –  “The cardiovascular CD34 clinical studies”
  • Mona NEMER, Ph.D., University of Ottawa, Ottawa, Canada –  “Cardiac Regeneration”
  • Marc RAAIJMAKERS, M.D., Ph.D., Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  • Mariusz RATAJCZAK, M.D., Ph. D., James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA – “Novel view on adult stem cell compartment”
  • Denis Claude ROY, MD, Centre de recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, Canada
  • David SMADJA, PU-PH, Université Paris Descartes, Inserm UMR-S1140, AP-HP, European Georges Pompidou Hospital, Paris, France – “From Very small embryonic like stem cells to endothelial progenitor cells: which is the best vasculogenic stem cell in adult ?”
  • Dr Romain BARBET, Ph. D., IRHT, Mulhouse, France – “Is Mesenchymal Inflammatory Status Driving the Hematopoietic Stem”
  • Dr Anne ARIES Ph. D., IRHT, Mulhouse, France
  • Dr Rachid LAHLIL, Ph. D., IRHT, Mulhouse, France
  • Dr Claire SAUCOURT, Ph. D., Cellprothera, Mulhouse, France
  • Anthony CRIQUET, Cellprothera, Mulhouse, France
  • Tauseef Ahmed, MD, Westchester Medical Center and New York Medical College, Valhalla, NY, USA